| |
| |
|
| Insider
Information: |
Amado Rafael |
| Relationship: |
Director |
| City: |
Malvern |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
622,015 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$612,762 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
622,015 |
|
|
| Total
Value |
$612,762 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adaptimmune Therapeutics PLC |
ADAP |
President, R&D |
2019-08-06 |
17,237 |
|
0 |
Premium* |
|
|
Allogene Therapeutics, Inc. |
ALLO |
|
2022-10-07 |
541,946 |
2019-09-03 |
0 |
Premium* |
|
|
Zai Lab Ltd |
ZLAB |
|
2024-04-04 |
23,532 |
2022-12-30 |
0 |
Premium* |
|
|
Poseida Therapeutics, Inc. |
PSTX |
Director |
2023-05-01 |
39,300 |
2023-05-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
27 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
27 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
